Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FD622
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injector units. This firm fixed-price, competitively awarded contract was issued on October 24, 2025, with completion expected by November 17, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Skyrizi is a biologic medication used to treat inflammatory skin conditions, representing the type of specialized pharmaceutical product that the Defense Logistics Agency procures to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that enables comprehensive pharmaceutical supply across multiple therapeutic domains for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards encompassing brand-name and generic medications, vaccines, and specialized medical supplies. The absence of a set-aside designation indicates this award was made through open competition, consistent with the company's demonstrated capability to meet federal procurement requirements for medical commodities supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FD622?
SPE2DR26FD622 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26FD622 worth?
The government has obligated $12,467 on SPE2DR26FD622.
Is contract SPE2DR26FD622 an order under another contract?
Yes. SPE2DR26FD622 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD622 competed?
The extent of competition for SPE2DR26FD622 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award